American Healthcare REIT (NYSE:AHR) Releases Earnings Results, Beats Estimates By $0.40 EPS

Posted by Geri Gentry on Aug 6th, 2026

American Healthcare REIT (NYSE:AHR – Get Free Report) announced its earnings results on Thursday. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.14 by $0.40, Zacks reports. American Healthcare REIT had a net margin of 4.23% and a return on equity of 3.33%. The business had revenue of $445.63 million during the quarter, compared to analysts’ expectations of $645.30 million. During the same quarter in the prior year, the company posted $0.42 earnings per share. The firm’s revenue was up 24.3% on a year-over-year basis. American Healthcare REIT updated its FY 2026 guidance to 2.150-2.190 EPS.

American Healthcare REIT Price Performance

Shares of AHR stock traded down $0.59 during trading on Thursday, hitting $54.91. The company had a trading volume of 2,050,158 shares, compared to its average volume of 2,912,224. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.45 and a current ratio of 0.45. The firm has a market capitalization of $10.58 billion, a P/E ratio of 94.67, a price-to-earnings-growth ratio of 1.82 and a beta of 0.76. The stock’s 50-day moving average price is $52.03 and its 200 day moving average price is $50.66. American Healthcare REIT has a one year low of $39.31 and a one year high of $58.70.

American Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th were given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Tuesday, June 30th. American Healthcare REIT’s payout ratio is presently 172.41%.

Analyst Ratings Changes

A number of analysts have commented on the stock. UBS Group increased their price target on shares of American Healthcare REIT from $60.00 to $63.00 and gave the company a “buy” rating in a research note on Wednesday, July 8th. Weiss Ratings downgraded American Healthcare REIT from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 2nd. Citizens Jmp increased their price target on American Healthcare REIT from $60.00 to $65.00 and gave the company a “market outperform” rating in a research note on Monday, July 27th. Barclays began coverage on shares of American Healthcare REIT in a research report on Tuesday, July 7th. They set an “overweight” rating and a $61.00 price objective for the company. Finally, Citigroup reissued an “outperform” rating on shares of American Healthcare REIT in a research report on Monday, July 27th. Twelve research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, American Healthcare REIT has an average rating of “Moderate Buy” and an average target price of $58.83.

Read Our Latest Research Report on American Healthcare REIT

Insiders Place Their Bets

In other American Healthcare REIT news, CFO Brian Peay sold 25,000 shares of the firm’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $50.70, for a total transaction of $1,267,500.00. Following the transaction, the chief financial officer owned 152,700 shares in the company, valued at $7,741,890. This trade represents a 14.07% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Mark E. Foster sold 2,500 shares of American Healthcare REIT stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $48.58, for a total value of $121,450.00. Following the completion of the transaction, the executive vice president directly owned 52,995 shares of the company’s stock, valued at $2,574,497.10. This represents a 4.50% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 29,500 shares of company stock worth $1,485,590. Corporate insiders own 0.75% of the company’s stock.

Institutional Investors Weigh In On American Healthcare REIT

Several institutional investors and hedge funds have recently bought and sold shares of the company. Garton & Associates Financial Advisors LLC acquired a new stake in American Healthcare REIT during the fourth quarter worth about $26,000. Kemnay Advisory Services Inc. acquired a new position in shares of American Healthcare REIT in the 4th quarter valued at approximately $29,000. Los Angeles Capital Management LLC acquired a new position in shares of American Healthcare REIT in the 4th quarter valued at approximately $34,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of American Healthcare REIT during the 4th quarter worth approximately $35,000. Finally, IFC & Insurance Marketing Inc. acquired a new stake in shares of American Healthcare REIT during the 4th quarter worth approximately $38,000. Institutional investors own 16.68% of the company’s stock.

About American Healthcare REIT

(Get Free Report)

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.